#arrowhead
Latest news and interesting information about arrowhead.
Wolfe Research Reaffirms Ionis Stock Outperform Rating
Wolfe Research reiterates Outperform rating on Ionis Pharmaceuticals stock. Analysis of Arrowhead competition and financial results.
Arrowhead director sells $228,333 in stock
Arrowhead Pharmaceuticals director Lu Hongbo sold $228,333 in stock. Shares trade at $79.69 near 52-week high.
...

